ESMO 2022 Conference Coverage


 

ESMO 2022 on the HIPECT4 Randomized Phase 3 Study: Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Locally Advanced Colon Cancer

855 views
September 16, 2022
Comments 0
Login to view comments. Click here to Login